While functional studies have classified these variants as loss-of-function in CD due to reduced NF-κB activation (29–31), IBD models and CD patients without NOD2 mutations also display impaired proinflammatory cytokine production (32, 33). This evidence concerns the gene NFKB1 and inflammatory bowel disease.